Calliditas Therapeutics
Susan Zogheib is a Rare Disease Account Manager and National Field Sales Trainer at Calliditas Therapeutics. Susan also serves as a Medical Advisor at WebMD. Susan has a strong background in the pharmaceutical and healthcare industry, with previous roles including Executive Renal Account Specialist at AstraZeneca and Regional Business Manager at Takeda. Additionally, Susan has experience in renal sales training and consultancy roles. Susan holds a MHS in Nutrition Communication from Ryerson University and a B.S. in Coordinated Dietetics from Rutgers University.
This person is not in any offices
Calliditas Therapeutics
2 followers
Calliditas Therapeutics AB is a specialty pharmaceutical company based in Stockholm, Sweden. It is focused on developing high quality pharmaceutical products for patients with a significant unmet medical need in niche indications, in which Calliditas can partially or completely participate in the commercialization efforts. Calliditas is focused onthe development and commercialization of the product candidate Nefecon, a unique two step formulation optimized to combine a time lag effect with a concentrated release of the active substance budesonide, within a designated target area. This patented, locally acting formulation is intended for treatment of patients with the inflammatory renal disease IgA nephropathy (IgAN). Calliditas is running a global Phase 3 study within IgAN and aims to commercialize Nefecon in the United States.